Alicja Debska-Slizien

Author PubWeight™ 7.35^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.	Artif Organs	2010	1.00
2	Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease.	J Am Soc Echocardiogr	2006	0.93
3	Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients.	Blood Coagul Fibrinolysis	2004	0.80
4	Treatment with recombinant human erythropoietin is associated with rejuvenation of CD8+ T cell compartment in chronic renal failure patients.	Nephrol Dial Transplant	2007	0.80
5	Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients.	Nephrol Dial Transplant	2004	0.79
6	The QUEST initiative anemia study in transplant patients: rationale and study protocol.	J Nephrol	2007	0.78
7	The QUEST initiative anemia study in ESRD: rationale and study protocol.	J Nephrol	2007	0.78
8	The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial.	Ann Transplant	2010	0.76
9	No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.	Mediators Inflamm	2004	0.75
10	Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.	Arch Med Res	2006	0.75